Acryl: Q1 2026 Revenue KRW 6.57B, Up 124% YoY, Operating Loss Narrows

Q1 2026 consolidated revenue KRW 6.57B (up 124% YoY from KRW 2.94B)
Consolidated operating loss KRW 0.79B (narrowed from KRW 1.62B loss in Q1 2025)
Consolidated net loss KRW 0.69B (down from KRW 1.62B loss)
Cash and cash equivalents KRW 41.48B; debt ratio 24.6%
Main product 'Jonathan' revenue share increased to 79.6% (from 52.3% in FY2025)
Credit rating upgraded to BB (NICE D&B, as of 2026.04.29)
R&D expenses KRW 0.46B (70.2% of sales); holds 85 patents
Subsidiary Fine Healthcare: net loss KRW 0.13B in Q1, accumulated losses continue